Cytokinetics/ US23282W6057 /
| 9/28/2023 9:59:54 PM | Chg. +0.88 | Volume | Bid- | Ask- | High | Low |
|---|---|---|---|---|---|---|
| 30.79USD | +2.94% | 36,797 Turnover: 1.13 mill. |
-Bid Size: - | -Ask Size: - | 31.67 | 28.96 |
GlobeNewswire
3/24/2022
Cytokinetics Announces Four Upcoming Presentations at the American College of Cardiology 71st Annual...
GlobeNewswire
3/17/2022
Ring Therapeutics Announces the Appointment of Industry Leaders to its Board of Directors
GlobeNewswire
3/1/2022
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
GlobeNewswire
2/28/2022
Cytokinetics Joins Global Initiative to Recognize International Rare Disease Day
GlobeNewswire
2/23/2022
Cytokinetics Announces Start of SEQUOIA-HCM, a Phase 3 Clinical Trial of Aficamten in Patients With ...
GlobeNewswire
2/16/2022
Cytokinetics and the American Heart Association Bay Area Announce a Three-Year Collaboration to Adva...
GlobeNewswire
2/8/2022
Rain Therapeutics Continues to Strengthen its Leadership Team with Key Appointments
GlobeNewswire
2/4/2022
Cytokinetics Announces FDA Acceptance of New Drug Application for Omecamtiv Mecarbil for the Treatme...
GlobeNewswire
2/1/2022
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
1/24/2022
Cytokinetics Announces Recipients of Fourth Annual Communications Fellowship Grants
GlobeNewswire
1/20/2022
Annexon Biosciences Appoints Bettina M. Cockroft, M.D. to its Board of Directors
GlobeNewswire
1/10/2022
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
1/7/2022
Royalty Pharma and Cytokinetics Announce Funding Agreements Totaling up to $450 Million
GlobeNewswire
1/7/2022
Cytokinetics and Royalty Pharma Announce Funding Agreements Totaling up to $450 Million
GlobeNewswire
1/6/2022
Terns Pharmaceuticals Appoints Jeffrey R. Jasper, Ph.D., as Senior Vice President, Head of Research ...
GlobeNewswire
1/3/2022
Cytokinetics to Participate in the 40th Annual J.P. Morgan Healthcare Conference